NEW YORK (Reuters Health) – Current evidence is still inconclusive as to whether patients with chronic kidney disease (CKD) may benefit from aggressive blood pressure control, according to…
NEW YORK (Reuters Health) – A low-dose regimen of peginterferon, without ribavirin, produces a sustained virologic response in up to 40% of patients with chronic hepatitis C and…
NEW YORK (Reuters Health) — Patients with chronic kidney disease (CKD) who are administered sodium bicarbonate before emergency coronary procedures might be less likely to suffer contrast-induced nephropathy…
NEW YORK (Reuters Health) – In older adults, mean serum levels of 25-hydroxyvitamin D are somewhat higher after a year of taking cholecalciferol (vitamin D3) compared to ergocalciferol…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD), an impaired platelet response clopidogrel independently contributes to worse outcomes after percutaneous coronary intervention (PCI), a…
NEW YORK (Reuters Health) – Nephron-sparing surgery is linked to better survival than radical nephrectomy for renal cell carcinoma, even among patients over age 80, study findings show.…
NEW YORK (Reuters Health) – After a first myocardial infarction, treatment with a calcium-channel blocker (CCB) does not appear to diminish the efficacy of clopidogrel, according to results…
NEW YORK (Reuters Health) – Putting patients on dialysis before they’re symptomatic offers no survival benefit; on the contrary, it may increase their risk of death, according to…
NEW YORK (Reuters Health) – Patients who begin dialysis when kidney disease is at a relatively early stage have an increased risk of dying in the following year,…
NEW YORK (Reuters Health) – Patients who develop acute renal failure (ARF) after undergoing coronary artery bypass grafting have a poorer prognosis if the condition doesn’t resolve within…